ResearchImproved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703
ResearchHigh Amphiregulin Expression in Intestinal Biopsies of Pediatric Patients with Severe Acute Graft-Versus-Host Disease
ResearchGraft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant
ResearchImpact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703
ResearchPlacental growth factor enhances inflammatory toll-like receptor responses in syncytiotrophoblasts
ResearchICANS and mortality after CAR-T therapy for NHL patients can be predicted using physical function measures of falls, balance and strength deficits, and use of an assistive device
ResearchSirolimus use in allogeneic hematopoietic cell transplant recipients: assessing its senotherapeutic role in a high risk population
ResearchAnalysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients
ResearchAmphiregulin as a biomarker for monitoring lifethreatening acute graft--host disease: secondary analysis of two prospective clinical trials
ResearchThe development and flux of the University of Minnesota Survivorship Program: progress, challenges, and opportunities
ResearchLong- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial
ResearchTreatment-Sensitive and Treatment-Dependent Chronic Graft-versus-Host Disease Yield Superior Failure-Free and Overall Survival Compared to Treatment-Resistant Chronic Graft-versus-Host Disease
ResearchAmphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD
ResearchTreatment-Responsive Acute Graft-versus-Host Disease after Post-Transplantation Cyclophosphamide-Based Prophylaxis: Incidence and Clinical Outcomes